Update on sodium hyaluronates (previously published 060106): Does Medicare cover viscosupplementation treatment of the knee?
The following link is to an article from January 12, 2007 publishing the most recent guidelines for these services: • http://www.cignamedicare.com/articles/Jan07/cope5205.html Four interim Q codes are in effect for these products as of January 1, 2007, i.e. Q4083 (Hyalgan/supartz injection per does), Q4084 (Synvisc injection per dose), Q4085 (Euflexxa injection per dose), and Q4086 (Orthovisc injection per dose). These replace HCPCS codes J7317 and J7320 referenced in the June 2006 issue of “Frequently Asked Questions.” The remainder of the 011207 article details covered diagnoses, guidelines for repeat use, and guidelines for billing an evaluation and management service the same date as the joint injection of one of these drugs. For additional information see the attached CMS article: http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5459.pdf Previous FAQ (question #6 June 2006 issue): http://www.cignamedicare.com/articles/June06/cope4333C.
Related Questions
- What conditions are covered for acupuncture? (Many plans only cover the treatment of pain) Do Medicaid and Medicare cover acupuncture?
- Update on sodium hyaluronates (previously published 060106): Does Medicare cover viscosupplementation treatment of the knee?
- Does Medicare cover viscosupplementation treatment of the knee?
